Tag: CPAP Alternative
Health-E Commerce offers CPAP alternative
April 8, 2025HME News Staff
DALLAS – Health-E Commerce has launched a new telehealth collaboration with Daybreak to make sleep apnea testing and treatment available at the FSA Store and HSA Store. Participants will receive a convenient at-home sleep test that is analyzed by the Daybreak’s team of board-certified physicians. If treatment is needed, the company will send an at-home impression kit and corresponding shipping materials. Once the completed impression kit is returned, it takes two to three weeks for a...
Signifier meets CMS requirements for reimbursement
March 10, 2025HME News Staff
LONDON – Signifier Medical Technologies Limited has introduced its newest SKU, 18010, which features a hardware remote control specifically designed to meet CMS requirements for reimbursement. The company says the development ensures that its eXciteOSA therapy can be more readily accessible for Medicare and Medicaid beneficiaries. “eXciteOSA is a life-changing device helping patients address a root cause of sleep apnea and other sleep disorders,” said Mujtaba Chohan, head of finance...
Signifier’s CPAP alternative approved by Georgia Medicaid
February 17, 2025HME News Staff
LONDON – Signifier Medical Technologies has announced that its eXciteOSA non-invasive therapy for obstructive sleep apnea is now covered under Georgia Medicaid policy 1320, expanding access to more than 1.5 million people who live in the state. “This decision underscores the critical importance of providing accessible, effective solutions for Georgians living with obstructive sleep apnea,” said Akhil Tripathi, director and founder of Signifier. “By including eXciteOSA in Medicaid...
Rotech excited about CPAP alternative
December 20, 2024HME News Staff
ORLANDO, Fla. – Rotech Healthcare recently partnered with Signifier Medical Technologies to offer the eXciteOSA device as an alternative option for OSA, part of the provider’s commitment to serving all patients, says CEO Robin Menchen.
The eXciteOSA device allows daytime treatment for approximately 20 minutes twice a day for the initial treatment period, which is ideal for those patients who cannot tolerate CPAP treatment when trying to sleep, she said.
“Our...
Rotech to supply CPAP alternative
November 26, 2024HME News Staff
ORLANDO, Fla. – Rotech Healthcare has announced a supplier agreement with Signifier Medical Technologies to introduce the eXciteOSA device to payers, health care providers and patients to treat mild to moderate obstructive sleep apnea.
The eXciteOSA device, approved by the U.S. Food and Drug Administration, uses neuromuscular electrical stimulation to tone tongue muscles to maintain an open airway during sleep, improving sleep quality and overall health.
“Partnering...
Inspire Medical Systems gets green light for V
August 5, 2024HME News Staff
MINNEAPOLIS – Inspire Medical Systems has announced approval from the U.S. Food and Drug Administration for the Inspire V therapy system, which includes a next generation neurostimulator for the treatment of obstructive sleep apnea. The system also includes the associated Bluetooth patient remote and physician programmer. “We are thrilled to announce the FDA approval of our next generation Inspire neurostimulation system,” said Tim Herbert, chairman and CEO of Inspire Medical Systems....
Signifier’s CPAP alternative greenlighted by SC Medicaid
April 8, 2024HME News Staff
BOSTON – Signifier Medical Technologies has announced that its eXciteOSA therapy for sleep-disordered breathing is now covered by South Carolina’s Health Connections Medicaid program. This coverage opens new doors for patients 18 and older who have previously had limited access to advanced treatments for obstructive sleep apnea. "We are thrilled that eXciteOSA is now covered by Medicaid in South Carolina," states Akhil Tripathi, director and co-founder of Signifier. "This...
ProSomnus raises $10M
September 25, 2023HME News Staff
PLEASANTON, Calif. – ProSomnus, which makes a CPAP alternative for the treatment of obstructive sleep apnea, has completed a $10 million convertible preferred equity offering led by existing investors Spring Mountain Capital and Cetus Capital. The company will use the new capital to optimize its core business operations and support its strategic growth initiatives as it strives to achieve cash flow breakeven. “The completion of this financing fortifies our balance sheet as we continue...
Alternative OSA therapies? Providers are skeptical
April 7, 2023Theresa Flaherty, Managing Editor
YARMOUTH, Maine – Although alternative therapies to treat sleep apnea like nasal sprays, chest implants and dental appliances continue to flood the market, CPAP remains the gold standard, say HME providers.
In January, for example, Vivos Therapeutics received clearance from the U.S. Food and Drug Administration for its proprietary daytime-nighttime (DNA) appliance to treat OSA; in March, Inspire Medical, the maker of an FDA-approved neurostimulation device, received FDA approval to...
Inspire Medical sees significant growth in Q4
January 10, 2023HME News Staff
MINNEAPOLIS – Inspire Medical, the maker of an FDA-approved neurostimulation device to treat obstructive sleep apnea, expects revenue of $137.5 million to $137.9 million for the fourth quarter of 2022, about a 76% increase year over year. It expects revenue for the full year to be $407.5 million to $407.9 million, about a 75% increase compared to 2021. “We are very pleased with our strong preliminary revenue performance in the fourth quarter primarily driven by higher utilization at existing...